News
RKTO
1.425
-16.18%
-0.275
*News On Hoth Therapeutics Inc. (HOTH) Now Under RKTO
Dow Jones · 19h ago
ROCKET ONE ACCEPTED INTO AMD AI DEVELOPER PROGRAM TO ADVANCE SIMULATION OF NEXT-GENERATION NANOMAGNETIC AI ACCELERATOR ARCHITECTURE FOR AI, DEFENSE AND SPACE APPLICATIONS
Reuters · 1d ago
From biotech to orbit: Rocket One's AI and space re-brand sends shares flying
Reuters · 1d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
NASDAQ TRADE HALT <HOTH.O> VOLATILITY TRADING PAUSE AT 12:11 PM
Reuters · 2d ago
Hoth Therapeutics completes legal change of corporate name to Rocket One
TipRanks · 2d ago
Rocket One Rebrands From Hoth, Refocusing on Space Computing
TipRanks · 2d ago
Hoth Therapeutics Announces That Previously Disclosed Name Change To Rocket One, Trading Under Symbol 'RKTO,' To Take Effect May 28
Benzinga · 2d ago
HOTH THERAPEUTICS INC - ROCKET ONE TO BEGIN TRADING AS RKTO ON NASDAQ MAY 28, 2026
Reuters · 2d ago
HOTH THERAPEUTICS INC - ROCKET ONE HOLDS EXCLUSIVE RIGHTS TO NANOMAGNETIC AI CHIP TECHNOLOGY
Reuters · 2d ago
Hoth Therapeutics rebrands as Rocket One, adopts RKTO ticker on Nasdaq
PUBT · 2d ago
Press Release: Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications
Dow Jones · 2d ago
Hoth Therapeutics receives Notice of Allowance for HT-KIT from USPTO
TipRanks · 3d ago
U.S. Patent And Trademark Offices Issues Notice Of Allownace For Hoth Therapeutics' HT-KIT Therapeutic
Benzinga · 3d ago
Hoth Therapeutics wins US patent allowance for HT-KIT oncology platform
PUBT · 3d ago
Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform
Barchart · 3d ago
Weekly Report: what happened at HOTH last week (0518-0522)?
Weekly Report · 4d ago
Hoth Therapeutics Rebrands as Rocket One, Shifts to AI
TipRanks · 05/21 21:53
Hoth Therapeutics restructures, pivots to AI semiconductors and spintronic computing under Rocket One rebrand
PUBT · 05/21 20:26
More
Webull provides a variety of real-time RKTO stock news. You can receive the latest news about ROCKET ONE INC through multiple platforms. This information may help you make smarter investment decisions.
About RKTO
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).